Wallroth Donald E. 5
5 · Molecular Insight Pharmaceuticals, Inc. · Filed Feb 16, 2010
Insider Transaction Report
Form 5
Wallroth Donald E.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2009-09-25$3.93/sh+4,000$15,720→ 24,000 total - Exercise/Conversion
Common Stock
2009-09-22$3.93/sh+4,000$15,720→ 12,000 total - Exercise/Conversion
Common Stock
2009-09-24$3.93/sh+4,000$15,720→ 20,000 total - Exercise/Conversion
Common Stock
2009-09-28$3.93/sh+13,500$53,055→ 37,500 total - Disposition to Issuer
Common Stock
2009-08-22−13,500→ 0 total - Exercise/Conversion
Common Stock
2009-09-18$3.93/sh+8,000$31,440→ 8,000 total - Exercise/Conversion
Common Stock
2009-09-23$3.93/sh+4,000$15,720→ 16,000 total - Exercise/Conversion
Employee Stock Option (right to buy)
2009-09-25−4,000→ 0 totalExercise: $3.93From: 2009-08-22Exp: 2010-11-22→ Common Stock (4,000 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2009-09-28−13,500→ 0 totalExercise: $3.93From: 2009-08-22Exp: 2010-11-22→ Common Stock (13,500 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2009-09-18−8,000→ 0 totalExercise: $3.93From: 2009-08-22Exp: 2010-11-22→ Common Stock (8,000 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2009-09-22−4,000→ 0 totalExercise: $3.93From: 2009-08-22Exp: 2010-11-22→ Common Stock (4,000 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2009-09-23−4,000→ 0 totalExercise: $3.93From: 2009-08-22Exp: 2010-11-22→ Common Stock (4,000 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2009-09-24−4,000→ 0 totalExercise: $3.93From: 2009-08-22Exp: 2010-11-22→ Common Stock (4,000 underlying)
Footnotes (1)
- [F1]This is a portion of the option that was granted on May 12, 2009. The vesting was accelerated on August 22, 2009, with an exercise period till November 22, 2010.